HomeOGN • NYSE
add
Organon & Co
Previous close
$16.00
Day range
$15.75 - $16.10
Year range
$13.87 - $23.10
Market cap
4.08B USD
Avg Volume
3.97M
P/E ratio
3.14
Dividend yield
7.07%
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 1.58B | 4.15% |
Operating expense | 533.00M | -21.04% |
Net income | 359.00M | 518.97% |
Net profit margin | 22.69 | 493.98% |
Earnings per share | 0.87 | 0.00% |
EBITDA | 459.00M | 56.66% |
Effective tax rate | -73.43% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 763.00M | 84.30% |
Total assets | 12.75B | 15.80% |
Total liabilities | 12.26B | 5.67% |
Total equity | 493.00M | — |
Shares outstanding | 257.54M | — |
Price to book | 8.38 | — |
Return on assets | 7.83% | — |
Return on capital | 10.81% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 359.00M | 518.97% |
Cash from operations | 141.00M | -45.98% |
Cash from investing | -75.00M | -36.36% |
Cash from financing | -78.00M | 0.00% |
Net change in cash | 59.00M | -32.95% |
Free cash flow | 29.00M | -85.07% |
About
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but gets a third of its revenue from the United States. Wikipedia
Founded
2020
Headquarters
Website
Employees
10,000
